Mylan Inc arm gets US OK for Tolterodine tartrate tablets

By Admin
Mylan Inc said its arm Mylan Pharmaceuticals Inc has secured final approval from the U.S. Food and Drug Administration for its abbreviated new drug app...

Mylan Inc said its arm Mylan Pharmaceuticals Inc has secured final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for Tolterodine tartrate tablets of 1 mg and 2 mg respectively.

This product is the generic version of Pharmacia and Upjohn’s Detrol® Tablets.  It is indicated for treating overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.

Tolterodine tartrate tablets had U.S. sales of approximately $61.5 million for 12 months ending September 30, 2012 as per IMS Health.

Thirty six of these pending ANDAs are potential first-to-file opportunities, representing $21.2 billion in annual brand sales for 12 months ending June 30, 2012.

Mylan is a global pharmaceutical company that offers portfolio of more than 1,100 generic pharmaceutical and several brand medications. It also offers a wide range of antiretroviral therapies, on which about one-third of HIV/AIDS patients in developing countries depend. It also operates one of the largest active pharmaceutical ingredient manufacturers and currently markets products in about 150 countries and territories.

The company has a workforce of over 18,000 people and is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world.

It also operates a fully integrated specialty pharmaceuticals business, Mylan Specialty, which produces innovative medicinal therapies including EpiPen® auto-injector. 

Share
Share

Featured Articles

UPS Healthcare Addressing Connected Logistics Needs

UPS Healthcare is meeting increased need for integrated, globally connected healthcare logistics services in Republic of Ireland, where pharma is booming

HPV Vaccine 'Protects Males from Cancers' - Global Report

As a new report shows the human papillomavirus vaccine can also protect men and boys, we take a look at HPV vaccines, and their impact on world health

Tata Consultancy Report Shows AI in Healthcare on Rise

Tata Consultancy Services AI for Business Global Study shows that three-quarters of healthcare leaders are deploying AI to drive innovation and efficiency

McKinsey: Consumers Demand Data-driven Wellness Products

Medical Devices & Pharma

SpaceX Starlink Launch Boost for Indonesia Healthcare

Technology & AI

J&J Targets Supplier Sustainability to Cut Healthcare GHGs

Sustainability